Thank you , very interesting... " Interim resul
Post# of 146264
![](/assets/46931549/no_avatar_available_thumb.jpg)
" Interim results from dose-escalation phase 1 trial show partial responses in 10 patients .
On the safety front , however , there were serious and life-threatening treatment -related adverse evens "
So patients need to chose , die from cancer , or possibly from side effects of medicine .. those are common choices for cancer patients until now , possibly , I mean , things maybe changing.......
Go Leronlimab...
All , IMO as always..
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)